This can be can reacted with rapid advances in surgical management, including the use of such tools as stereotactic radiosurgery and auditory brainstem implants
Although care of the patient with NF2 can be done in the primary care setting, the complexity, rarity, and multi system involvement encountered in this condition suggest that medical care in a disease-specific, multidisciplinary clinic may permit best management.
This type is less common, representing about 10% of all neurofibromatosis cases. In New Zealand it is estimated that NF 2 affects about 1 in 50,000 people. It is caused by a defect on chromosome 22.